☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Herceptin
Top 20 Prescription Drugs Based on 2019 Revenue
July 17, 2020
Insights+ Key Biosimilars Events of August 2019
September 9, 2019
Amgen and Allergan's Kanjinti (biosimilar- trastuzumab) Receive the US FDA's Approval for All Approved Indications of Herceptin
June 14, 2019
Roche Reports Results of Kadcyla (trastuzumab emtansine) in P-III KATHERINE Study for HER2-positive Early Breast Cancer (eBC)
December 6, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.